These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 14452

  • 41. [An analysis of the distribution by molecular weight of an aggregate of biologically active compounds taking into account their possible penetration through gap-junction channels].
    Gudoshnikov VI, Fedotov VP.
    Izv Akad Nauk SSSR Biol; 1990; (4):622-5. PubMed ID: 1980280
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
    Heikkila RE, Cohen G.
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
    [No Abstract] [Full Text] [Related]

  • 44. GABA and central monoamine release.
    Yessaian NH.
    Vopr Biokhim Mozga; 1978 Mar; 13():267-78. PubMed ID: 41366
    [No Abstract] [Full Text] [Related]

  • 45. The effects of neurohormones and biogenic amines on contractile reactivity of the rabbit spleen in vitro.
    Lozowski SZ.
    Acta Physiol Pol; 1975 Mar; 26(1):71-8. PubMed ID: 1130221
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Biogenic amines in the etiology of hypertensive conditions in children].
    Komarova LG, Lozovskaia LI, Miasnikova II, Patarakina AA, Antipina ZhV.
    Pediatriia; 1973 Apr; 52(4):14-7. PubMed ID: 4771500
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Amines in mental disorders (author's transl)].
    Takahashi R.
    Tanpakushitsu Kakusan Koso; 1977 Apr; 22(6):815-21. PubMed ID: 337391
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Interaction of opiates and opioid peptides with cerebral mediator systems].
    Bulaev VM, Raevskiĭ KS.
    Usp Fiziol Nauk; 1982 Apr; 13(2):65-92. PubMed ID: 6124068
    [No Abstract] [Full Text] [Related]

  • 53. [Recent advances in biochemical studies of dementia in the elderly].
    Nishimura T, Yamashita T, Tada K, Cacabelos R, Niikawa H, Suzuki H.
    No To Shinkei; 1987 Jan; 39(1):9-16. PubMed ID: 2881562
    [No Abstract] [Full Text] [Related]

  • 54. [Status of mediator metabolism in neurasthenia].
    Parmenov-Trifilov BI, Shapovalov SL, Lysenko AS.
    Voen Med Zh; 1972 Jun; 6():76-82. PubMed ID: 4404130
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The properties and potential function of some brain trace amines.
    Boulton AA.
    Prog Clin Biol Res; 1980 Jun; 39():291-303. PubMed ID: 6105673
    [No Abstract] [Full Text] [Related]

  • 58. Relationship between antitumor effect of polysaccharides and biogenic amines in tumor tissues.
    Ikekawa T, Sano M, Okabe M, Fukuoka F.
    Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2148-50. PubMed ID: 1182919
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.